This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bright R. Cases and observations, illustrative of renal disease accompanied with the secretion of albuminous urine. Guys Hosp Rep 1836, 1:338.
Naets JP, Garcia JF, Toussaint C et al. Radioimmunoassay of erythropoietin in chronic uremia or anephric patients. Scand J Haematol 1986, 37:390–394.
London G, Marchais S, Guerin AP. Blood pressure control in chronic hemodialysis patients. In Replacement of Renal Function by Dialysis, 4th Edition. Edited by C Jacobs, CM Kjellstrand, KM Koch and JF Winchester. Dordrecht: Kluwer, 1996:966–990.
Charra B. Personal communication.
Wallner SF, Vautrin RM. Evidence that inhibition of erythropoiesis is important in the anemia of chronic renal failure. J Lab Clin Med 1981, 97:170.
Moritz JL, Jensen WM, Ahmad S. Prospective study in patients on low dose of recombinant erythropoietin (Epo): hematocrit (HCT), blood pressure and hemodynamic responses. J Am Soc Nephrol 1990, 1:403.
Fishbane S, Maesaka JK. Iron management in end-stage renal disease. Am J Kidney Dis. 1997, 29:319.
Gupta A, Amin NB, Besars A et al. Dialysate iron therapy: infusion of ferric pyrophosphate via the dialysate in maintenance hemodialysis (HD) patients. J Am Soc Nephrol 1998, 9:251A.
Labonia WD. L-carnitine effects on anemia in hemodialyzed patients treated with erythropoietin. Am J Kidney Dis 1995, 26:757.
Labonia WD, Morelli OH, Gimenez MI et al. Effects of L-carnitine on sodium transport in erythrocytes from dialyzed uremic patients. Kidney Int 1987, 32:754–759.
Megri K, Trombert JC, Zannier A. Role of L-carnitine deficiency in persistent anemia of maintenance hemodialysis (MHD) patients treated by erythropoietin(EPO) [Abstract]. Societe Francaise De Nephrologie Toulouse. 1997; 153.
Barrillon D, Cassuto-Viguier E, Iordache A et al. Role of L-carnitine deficiency in persistent anemia of maintenance hemodialysis (MHD) patients treated by erythropoietin(EPO) [Abstract]. Societe Francaise De Nephrologie Nantes. 1992; 103.
Savica V, Bellinghieri G, Mallamace A. Value of carnitine in periodic hemodialysis. Rass Med Interna 1986, 7:293–307.
Nilsson-Ehle P, Cederblad G, Fagher B et al. Plasma lipoproteins, liver function and glucose metabolism in haemodialysis patients: lack of effect of L-carnitine supplementation. Scand J Clin Lab Invest 1985, 45:179–184.
Bellingheri G, Savica V, Mallamace A et al. Correlation between increased serum and tissue L-carnitine levels and improved muscle symptoms in hemodialyzed patients. Am J Clin Nutr1983, 38:523–531.
Donatelli M, Terrizzi C, Zummo G et al. Effects of L-carnitine on chronic anemia and erythrocyte adenosine triphosphate concentration in hemodialyzed patients. Curr Ther Res 1987, 41:620–624.
Mioli V, Tarchini R, Boggi R. Use of D, L-, and L-carnitine in uraemic patients on intermittent haemodialysis. Int J Clin Pharm Res 1982, 2:143–148.
Trovato G, Ginardi V, Di Marco V et al. Long term l-carnitine treatment of chronic anemia of patients with end-stage renal failure. Curr Ther Res1982, 31:1042.
Caruso U, Leone L, Cravotto E et al. Effects of l-carnitine on anemia in aged hemodialysis patients treated with recombinant human erythropoietin. Dial Transplant 1998, 27:498.
Thompson CH, Irish AB, Kemp GJ et al. The effect of propionyl L-carnitine on skeletal muscle metabolism in renal failure. Clin Nephrol. 1997, 47:372–378.
Albertazzi A, Capelli P, Di-Paolo B et al. Endocrine-metabolic effects of l-carnitine in patients on regular dialysis treatment. Proc Eur Dial Transplant Assoc 1983, 19:302–307.
Matsumura M, Hatakeyama S, Koni I et al. Correlation between serum carnitine levels and erythrocyte osmotic fragility in hemodialysis patients. Nephron1996, 72:574–578.
Rights and permissions
Copyright information
© 2009 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
(2009). Anemia. In: Manual of Clinical Dialysis. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-09651-3_14
Download citation
DOI: https://doi.org/10.1007/978-0-387-09651-3_14
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-09650-6
Online ISBN: 978-0-387-09651-3
eBook Packages: MedicineMedicine (R0)